Sign in
CompletedNo phase

Hemogram Parameter Changes With Sepsis Filter

Key facts

Who runs it
Samsun University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
92 people enrolled
Started
1 Jan 2024
Ended
1 Feb 2024
Type of study
Observational
Record updated
29 April 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Data of patients who were monitored in the Intensive Care between January 2020 and December 2022 and who were applied sepsis filters

Who cannot take part

  • -Patients who underwent hemodiafiltration with sepsis filter but could not be followed for 72 hours (death, etc.)

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Hemodiafiltration is initiated in hemodynamically unstable patients in intensive care units. In some patients, additional devices called cytokine filters or sepsis filters are added to remove inflammatory cytokines. Data obtained from hemograms, such as platelet lymphocytosis ratio, are used in the diagnosis or prognosis of many diseases. This study focuses on the change in hemogram rates in patients who received hemofiltration and sepsis filters.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Change in Hemogram-Derived Ratios With Sepsis Filters:A Retrospective Cohort Study in the Intensive Care Unit
Record updated
29 April 2025